Avodart found to reduce prostate risk

(The New York Times) UPDATED 2009-05-07

A large clinical trial has found that the drug Avodart reduces the risk of prostate cancer. The study of 8,100 men who had elevated PSA levels found that Avodart (dutasteride) reduced the risk of all biopsy-detectable prostate cancer by 23 percent over four years when compared to a placebo. The study's authors say they did not find a higher incidence of high-grade tumors, which is a problem that previously plagued rival drug Proscar. Read full story >

See all Prostate News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Avodart found to reduce prostate risk

People who read this also read...

What the community is saying...

Prostate Cancer: Radiation Therapy Options

Jay Motola